Altered innate immune profile in blood of systemic mastocytosis patients.
cytokines
dendritic cells
microenvironment
monocyte
systemic mastocytosis
Journal
Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
16
02
2022
revised:
26
04
2022
accepted:
21
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
Mast cells (MC) from systemic mastocytosis (SM) patients release MC mediators that lead to an altered microenvironment with potential consequences on innate immune cells, such as monocytes and dendritic cells (DC). Here we investigated the distribution and functional behaviour of different populations of blood monocytes and DC among distinct diagnostic subtypes of SM. Overall, we studied 115 SM patients - 45 bone marrow mastocytosis (BMM), 61 indolent SM (ISM), 9 aggressive SM (ASM)- and 32 healthy donors (HD). Spontaneous and SM patients showed increased plasma levels and spontaneous production by blood monocytes of IL1β, IL6, IL8, TNFα and IL10, associated with an exhausted ability of LPS + IFNγ-stimulated blood monocytes to produce IL1β and TGFβ. SM (particularly ISM) patients also showed decreased counts of total monocytes, at the expense of intermediate monocytes and non-classical monocytes. Interestingly, while ISM and ASM patients had decreased numbers of plasmacytoid DC and myeloid DC (and their major subsets) in blood, an expansion of AXL These results demonstrate an altered distribution of blood monocytes and DC subsets in SM associated with constitutive activation of functionally impaired blood monocytes and increased plasma levels of a wide variety of inflammatory cytokines, reflecting broad activation of the innate immune response in mastocytosis.
Sections du résumé
Background
UNASSIGNED
Mast cells (MC) from systemic mastocytosis (SM) patients release MC mediators that lead to an altered microenvironment with potential consequences on innate immune cells, such as monocytes and dendritic cells (DC). Here we investigated the distribution and functional behaviour of different populations of blood monocytes and DC among distinct diagnostic subtypes of SM.
Methods
UNASSIGNED
Overall, we studied 115 SM patients - 45 bone marrow mastocytosis (BMM), 61 indolent SM (ISM), 9 aggressive SM (ASM)- and 32 healthy donors (HD). Spontaneous and
Results
UNASSIGNED
SM patients showed increased plasma levels and spontaneous production by blood monocytes of IL1β, IL6, IL8, TNFα and IL10, associated with an exhausted ability of LPS + IFNγ-stimulated blood monocytes to produce IL1β and TGFβ. SM (particularly ISM) patients also showed decreased counts of total monocytes, at the expense of intermediate monocytes and non-classical monocytes. Interestingly, while ISM and ASM patients had decreased numbers of plasmacytoid DC and myeloid DC (and their major subsets) in blood, an expansion of AXL
Conclusion
UNASSIGNED
These results demonstrate an altered distribution of blood monocytes and DC subsets in SM associated with constitutive activation of functionally impaired blood monocytes and increased plasma levels of a wide variety of inflammatory cytokines, reflecting broad activation of the innate immune response in mastocytosis.
Identifiants
pubmed: 35734269
doi: 10.1002/clt2.12167
pii: CLT212167
pmc: PMC9194602
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e12167Informations de copyright
© 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
Déclaration de conflit d'intérêts
Authors declared no conflicts of interest.
Références
Front Immunol. 2015 Aug 07;6:394
pubmed: 26300882
Haematologica. 2020 Jan;105(1):5-6
pubmed: 31894094
Clin Sci (Lond). 2003 Jan;104(1):27-38
pubmed: 12519085
J Allergy Clin Immunol Pract. 2020 Jan;8(1):292-301.e2
pubmed: 31319217
Biochem Biophys Res Commun. 2007 Feb 2;353(1):133-8
pubmed: 17174274
J Allergy Clin Immunol. 2022 Jul;150(1):146-156.e10
pubmed: 35026208
Annu Rev Immunol. 2009;27:451-83
pubmed: 19105661
PLoS Biol. 2008 Dec 2;6(12):2853-68
pubmed: 19053174
Clin Exp Allergy. 2018 Nov;48(11):1412-1420
pubmed: 29939445
Immunity. 1999 Feb;10(2):137-42
pubmed: 10072066
J Allergy Clin Immunol. 2013 Apr;131(4):1213-24, 1224.e1-4
pubmed: 23403045
Mol Immunol. 2015 Jan;63(1):94-103
pubmed: 24671125
J Exp Med. 2020 Mar 2;217(3):
pubmed: 31845972
FASEB J. 2013 Dec;27(12):4757-67
pubmed: 23964081
Biochim Biophys Acta. 2012 Jan;1822(1):21-33
pubmed: 21185371
Science. 1993 Mar 19;259(5102):1739-42
pubmed: 8456300
Int J Biochem Cell Biol. 1999 Oct;31(10):1053-74
pubmed: 10582339
Int Rev Cell Mol Biol. 2019;349:177-211
pubmed: 31759431
J Allergy Clin Immunol. 2013 Nov;132(5):1234-1237.e7
pubmed: 23910691
Mucosal Immunol. 2010 Mar;3(2):111-28
pubmed: 20043008
Annu Rev Pathol. 2010;5:99-118
pubmed: 20078217
Curr Hematol Rep. 2004 May;3(3):197-202
pubmed: 15087068
Immunobiology. 2006;211(6-8):463-72
pubmed: 16920486
J Immunol. 2003 Mar 15;170(6):3037-45
pubmed: 12626558
Haematologica. 2020 Jan;105(1):124-135
pubmed: 30948489
Leuk Lymphoma. 2005 Feb;46(2):247-55
pubmed: 15621809
Leukemia. 2017 Oct;31(10):2094-2103
pubmed: 28104919
Front Immunol. 2021 Jun 10;12:666953
pubmed: 34177905
Leukemia. 2012 Sep;26(9):1986-2010
pubmed: 22948490
Crit Rev Immunol. 2011;31(6):475-529
pubmed: 22321108
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Cancer Cell. 2005 Mar;7(3):211-7
pubmed: 15766659
Blood. 2006 Oct 1;108(7):2366-72
pubmed: 16741248
J Allergy Clin Immunol. 2021 Apr;147(4):1490-1496.e2
pubmed: 33091410
J Neuroimmunol. 2003 May;138(1-2):115-22
pubmed: 12742661
Inflamm Allergy Drug Targets. 2006 Jan;5(1):61-77
pubmed: 16613565
Nature. 1990 Jul 19;346(6281):274-6
pubmed: 2374592
Blood. 2017 Mar 16;129(11):1420-1427
pubmed: 28031180
Front Immunol. 2016 Jan 06;6:620
pubmed: 26779180
Nat Rev Cancer. 2004 Jan;4(1):71-8
pubmed: 14708027
Nat Commun. 2019 Apr 30;10(1):1999
pubmed: 31040289
Scand J Immunol. 2006 Jul;64(1):10-6
pubmed: 16784486
Eur J Pharmacol. 2016 May 5;778:84-9
pubmed: 25941086
Front Immunol. 2012 May 25;3:120
pubmed: 22654879
Trends Immunol. 2020 Dec;41(12):1062-1071
pubmed: 33250080
Biochim Biophys Acta. 2003 Nov 20;1639(3):141-51
pubmed: 14636945
Dtsch Arztebl Int. 2008 Oct;105(40):686-92
pubmed: 19623287
Leukemia. 2016 Jan;30(1):124-30
pubmed: 26153655
Am J Clin Dermatol. 2011 Aug 1;12(4):259-70
pubmed: 21668033